Back to search

Article

CRISPR-enhanced human adipocyte “browning” as cell therapy for metabolic disease

2020-10-13

Abstract excerpt

Obesity and type 2 diabetes (T2D) are associated with poor tissue responses to insulin 1,2 , disturbances in glucose and lipid fluxes 3–5 and comorbidities including steatohepatitis 6 and cardiovascular disease 7,8 . Despite extensive efforts at prevention and treatment 9,10 , diabetes afflicts over 400 million people worldwide 11 . Whole body metabolism is regulated by adipose tissue depots 12–14 , which i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
69729b10-ca19-52a0-8aa8-d4b1242b5a07
DOI
10.1101/2020.10.13.337923
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR-enhanced human adipocyte “browning” as cell therapy for metabolic diseaseDOI 10.1101/2020.10.13.337923
Select a neighboring publication to make it the new centre.